[ON THE SYMPTOMATIC USE OF THE HYPNOTIC AND SEDATIVE CENTALUN IN INTERNAL DISEASES].
D003920:Diabetes Mellitus; D004381:Duodenal Ulcer; D005705:Gallbladder Diseases; D005756:Gastritis; D006018:Glycols; D006801:Humans; D006993:Hypnotics and Sedatives; D002537:Intracranial Arteriosclerosis; D008107:Liver Diseases
D006018:Glycols; D006993:Hypnotics and Sedatives; C004581:centalun
CENTALUN; CEREBRAL ARTERIOSCLEROSIS; DIABETES MELLITUS; DUODENAL ULCER; GALLBLADDER DISEASES; GASTRITIS; HYPNOTICS AND SEDATIVES; LIVER DISEASES
ZUR SYMPTOMATISCHEN ANWENDUNG DES BERUHIGUNGS- UND SCHLAFMITTELS CENTALUN BEI INNEREN KRANKHEITEN.